Colgate-Palmolive (NYSE:CL) Cut to Hold at StockNews.com

StockNews.com downgraded shares of Colgate-Palmolive (NYSE:CLGet Rating) from a buy rating to a hold rating in a report issued on Monday morning.

Several other analysts have also recently weighed in on the company. Deutsche Bank Aktiengesellschaft dropped their price objective on Colgate-Palmolive from $88.00 to $87.00 in a report on Tuesday, July 19th. Barclays upped their price target on Colgate-Palmolive from $71.00 to $74.00 and gave the company an equal weight rating in a research note on Tuesday, August 2nd. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $79.00 to $78.00 in a research note on Thursday, July 21st. Wells Fargo & Company raised Colgate-Palmolive to an equal weight rating in a research note on Tuesday, August 9th. Finally, UBS Group boosted their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the company a buy rating in a research report on Monday, August 1st. Thirteen investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of Hold and an average price target of $84.57.

Colgate-Palmolive Stock Up 0.4 %

Shares of NYSE:CL opened at $76.01 on Monday. Colgate-Palmolive has a 52 week low of $72.20 and a 52 week high of $85.61. The company has a debt-to-equity ratio of 14.26, a quick ratio of 0.72 and a current ratio of 1.17. The company’s fifty day moving average is $79.10 and its 200-day moving average is $78.11. The company has a market capitalization of $63.40 billion, a PE ratio of 32.90, a P/E/G ratio of 5.42 and a beta of 0.48.

Colgate-Palmolive (NYSE:CLGet Rating) last issued its earnings results on Friday, July 29th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. Colgate-Palmolive had a net margin of 10.98% and a return on equity of 315.10%. The company had revenue of $4.48 billion for the quarter, compared to the consensus estimate of $4.35 billion. During the same quarter in the previous year, the company earned $0.80 EPS. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. Equities research analysts predict that Colgate-Palmolive will post 3.03 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 15th. Investors of record on Friday, October 21st will be issued a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 2.47%. The ex-dividend date is Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 81.39%.

Insider Activity at Colgate-Palmolive

In related news, insider Jennifer Daniels sold 24,703 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $81.25, for a total transaction of $2,007,118.75. Following the sale, the insider now directly owns 48,163 shares in the company, valued at approximately $3,913,243.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CEO Noel R. Wallace sold 51,665 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $81.27, for a total value of $4,198,814.55. Following the transaction, the chief executive officer now owns 221,790 shares in the company, valued at approximately $18,024,873.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 24,703 shares of the business’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $81.25, for a total transaction of $2,007,118.75. Following the transaction, the insider now owns 48,163 shares in the company, valued at approximately $3,913,243.75. The disclosure for this sale can be found here. In the last three months, insiders have sold 125,802 shares of company stock valued at $10,100,532. 0.31% of the stock is owned by insiders.

Institutional Trading of Colgate-Palmolive

Hedge funds and other institutional investors have recently bought and sold shares of the business. TCI Wealth Advisors Inc. grew its position in Colgate-Palmolive by 76.0% during the second quarter. TCI Wealth Advisors Inc. now owns 315 shares of the company’s stock valued at $25,000 after buying an additional 136 shares during the period. Better Money Decisions LLC bought a new position in Colgate-Palmolive during the second quarter valued at about $25,000. Core Alternative Capital lifted its holdings in Colgate-Palmolive by 924.3% during the first quarter. Core Alternative Capital now owns 379 shares of the company’s stock valued at $29,000 after purchasing an additional 342 shares during the last quarter. Carl Stuart Investment Advisor Inc. purchased a new stake in Colgate-Palmolive during the first quarter valued at about $30,000. Finally, Investors Asset Management of Georgia Inc. GA ADV purchased a new stake in shares of Colgate-Palmolive in the second quarter worth about $35,000. Institutional investors own 78.62% of the company’s stock.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.